Pre-order Enquiry
Download Free Sample
Healthcare
Aerospace & Defence
Agriculture
Automations
Chemicals & Advanced Materials
Food & Beverages
Information & Communication Technology
Oil & Gas
Power & Energy
Nocturia, also known as nocturnal polyuria, is a medical condition in which patients get a frequent urge to urinate while sleeping at night. It is particularly prevalent among the elderly who often find it difficult to sleep properly. The three broad categories of nocturia are mixed nocturia, bladder storage problems, and nocturnal polyuria.
According to our Researcher latest study, the global Nocturia market size was valued at USD 2198.4 million in 2022 and is forecast to a readjusted size of USD 3454.8 million by 2029 with a CAGR of 6.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report is a detailed and comprehensive analysis for global Nocturia market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sale Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nocturia market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nocturia market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nocturia market size and forecasts, by Type and by Sale Channels, in consumption value ($ Million), 2018-2029
Global Nocturia market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nocturia
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nocturia market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly and GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Nocturia market is split by Type and by Sale Channels. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Market segment by Sale Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nocturia product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nocturia, with revenue, gross margin and global market share of Nocturia from 2018 to 2023.
Chapter 3, the Nocturia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nocturia market forecast, by regions, type and sale channels, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nocturia.
Chapter 13, to describe Nocturia research findings and conclusion.
According to our Researcher latest study, the global Nocturia market size was valued at USD 2198.4 million in 2022 and is forecast to a readjusted size of USD 3454.8 million by 2029 with a CAGR of 6.7% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Global core nocturia manufactures include Astellas Pharma, Allergan, Eli Lilly etc. The top 2 companies hold a share about 30%. North America is the largest market, with a share about 40%, followed by Europe and Asia Pacific with the share about 34% and 18%. In terms of product, alpha blockers is the largest segment, with a share over 37%.
This report is a detailed and comprehensive analysis for global Nocturia market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Sale Channels. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Nocturia market size and forecasts, in consumption value ($ Million), 2018-2029
Global Nocturia market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Nocturia market size and forecasts, by Type and by Sale Channels, in consumption value ($ Million), 2018-2029
Global Nocturia market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Nocturia
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Nocturia market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Astellas Pharma, Allergan, Ferring Pharmaceuticals, Eli Lilly and GlaxoSmithKline, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Nocturia market is split by Type and by Sale Channels. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Sale Channels. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Desmopressin
Anticholinergic Drugs
Alpha Blockers
Diuretics
Others
Market segment by Sale Channels
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by players, this report covers
Astellas Pharma
Allergan
Ferring Pharmaceuticals
Eli Lilly
GlaxoSmithKline
Sanofi
Pfizer
Abbott
Teva
Mylan
Johnson & Johnson
Hainan Zhonghe Pharmaceutical
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Nocturia product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Nocturia, with revenue, gross margin and global market share of Nocturia from 2018 to 2023.
Chapter 3, the Nocturia competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Nocturia market forecast, by regions, type and sale channels, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Nocturia.
Chapter 13, to describe Nocturia research findings and conclusion.
Frequently Asked Questions
This market study covers the global and regional market with an
in-depth analysis of the
overall growth prospects...
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by
highlighting information on
different aspects including drivers, restraints...
